Mobile app to increase Black participation in pancreatic cancer clinical trials

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to develop a culturally tailored mobile health application designed to enhance participation among Black individuals diagnosed with pancreatic cancer in discussions about clinical trials. By identifying barriers to enrollment and addressing the specific communication and education needs of this population, the study seeks to promote greater engagement with healthcare teams. The intervention includes semistructured interviews to gather feedback and refine the app's content and functionality. The ultimate goal is to improve clinical trial participation rates among Black patients, who face significant disparities in outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria

Participants must meet the following inclusion criteria in order to participate in communication \& education interview component of the study:

1. Informed consent obtained to participate in the study
2. 18 years or older
3. English speaking
4. Able and willing to participate in a 1-hour interview
5. History of pancreatic cancer diagnosis
6. Identify as Black

Exclusion Criteria:

All participants meeting any of the following exclusion criteria will be excluded from the study:

1. Inability to read and speak English
2. Dementia altered mental status, or any psychiatric condition that would prohibit understanding or rendering of informed consent as determined by the study physician.

Where it's running

• UNC Lineberger Comprehensive Cancer Center
  Chapel Hill, North Carolina, United States Recruiting
• Medical College Of Wisconsin
  Milwaukee, Wisconsin, United States Recruiting

Study contacts

• Principal investigator: Ashwin J omasundaram, MD — UNC Lineberger Comprehensive Cancer Center
• Study coordinator: Lori Stravers
• Email: lori_stravers@med.unc.edu
• Phone: 1 919-966-4432

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Liquid biopsy biomarkers to detect and monitor pancreatic cancer

  Researchers test blood-based microRNA signals to see if they can identify pancreatic cancer risk or early disease in people with familial or hereditary risk or mucinous cysts.

  Recruiting Università Vita-Salute San Raffaele · Milan, MI · NCT07700992

• INSPIRE: Putting patient-reported info into multidisciplinary tumor boards

  This study tests whether adding electronic patient-reported outcomes to tumor board discussions can help guide treatment decisions for women with breast, gynecologic, pancreatic cancers and related cancers.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama and 2 other locations · NCT07671937

• MRI scan for detecting pancreatic cancer in people at high risk

  This study tests a dedicated pancreas MRI (MRP) tool to see if it helps find pancreatic cancer earlier in people with a strong family or genetic risk.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07612046

• Cutting down ultra-processed foods for people at high cancer risk

  This project tests whether using the Open Food Facts smartphone app alongside nutrition education helps adults at high risk of cancer eat fewer ultra-processed foods.

  Recruiting at 2 sites Gustave Roussy, Cancer Campus, Grand Paris · Avignon and 2 other locations · NCT07436312

• Carbon nanoparticle‑loaded iron for advanced solid tumors

  This test uses direct injections of a carbon nanoparticle‑loaded iron medicine (CNSI‑Fe) to see if it can shrink tumors in adults with advanced solid cancers who have no effective standard treatment options.

  Recruiting at 4 sites Phase 1/2 Sichuan Enray Pharmaceutical Sciences Company · Beijing, Beijing Municipality and 8 other locations · NCT07433283

• Axelopran for adults with advanced breast, lung, pancreas, or prostate cancer who take opioids

  This trial will test whether taking axelopran can slow tumor progression, help bowel problems, and reduce inflammation in adults with advanced breast, lung, pancreas, or prostate cancer who are using opioid pain medicines.

  Recruiting at 2 sites Phase 2 HealthPartners Institute · Saint Louis Park, Minnesota and 1 other locations · NCT07354919

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.